Due to their precise nature, research antibodies are essential laboratory tools. Hundreds of companies commercially supply research antibodies to locations worldwide. We at The Science Advisory Board found that many scientists use pre made antibodies, in addition to custom antibodies that they purchase, make in their lab, or share with colleagues for less common applications.
We collaborated with BenchSci to better understand how Artificial Intelligence will shape the future of drug discovery, and what the barriers to entry are. We surveyed 330 members of the science advisory board to get their opinions on the subject, and hear about their experiences with Artificial Intelligence in drug discovery thus far. Click here to find out what we discovered.
After a brief hiatus, we are relaunching our charity donation program, with donations to Direct Relief and the Tri-Beta Society. They are both doing excellent work in their fields and we are proud to be able to facilitate such generous giving from you, our members. Click here to learn more about what's changed, and how your donated points are being put to good use.
The emergence of CRISPR-Cas9 research is one of those rare developments in scientific history where a very complicated, difficult to understand issue has captured the imaginations of the media, and subsequently the public. Find out what our members have to say about the controversial topic of CRISPR-Cas9 engineered gene drives.
The Science Advisory Board has conducted opinion research regarding The Food & Drug Administration (FDA), and federal regulations' effect on drug prices. This survey talks about the Trump Administration's proposed budget cuts and policy changes that would affect the FDA. It also enquires about Scott Gottlieb's nomination to lead the agency, the FDA's approval process and probe at the causes of increasing drug prices.
The Science Advisory Board has conducted a research study on the recent changes in the Environmental Protection Agency (EPA) under the Trump Administration and casted it amongst a wide range of EPA employees, environmental scientists, and scientists working for the … Read more
Shortly after the inauguration of 45th President, the United States Department of Agriculture (USDA) received an internal communication calling for a suspension of “public-facing documents”. Although not unprecedented, it marked the beginning of what looks to be a long term … Read more
Following the election of Donald Trump as President Elect The Science Advisory Board published a poll to gauge the response of the scientific community, both within the USA and around the world. Our findings support the media’s portrayal of a … Read more
New data from the 2016 Clinical Trial Overview (CTO), an opinion study of 1,000 published clinical trial scientists conducted by The Science Advisory Board, highlights flaws in the process of clinical trials from an insider’s perspective. To provide additional context, … Read more